Cargando…

Emerging Roles of C-Myc in Cancer Stem Cell-Related Signaling and Resistance to Cancer Chemotherapy: A Potential Therapeutic Target Against Colorectal Cancer

Myc is a nuclear transcription factor that mainly regulates cell growth, cell cycle, metabolism, and survival. Myc family proteins contain c-Myc, n-Myc, and l-Myc. Among them, c-Myc can become a promising therapeutic target molecule in cancer. Cancer stem cells (CSCs) are known to be responsible for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elbadawy, Mohamed, Usui, Tatsuya, Yamawaki, Hideyuki, Sasaki, Kazuaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6539579/ https://www.ncbi.nlm.nih.gov/pubmed/31083525 http://dx.doi.org/10.3390/ijms20092340

Ejemplares similares

Emerging Roles of Cancer Stem Cells in Bladder Cancer Progression, Tumorigenesis, and Resistance to Chemotherapy: A Potential Therapeutic Target for Bladder Cancer
por: Abugomaa, Amira, et al.
Publicado: (2020)

Development of an Experimental Model for Analyzing Drug Resistance in Colorectal Cancer
por: Elbadawy, Mohamed, et al.
Publicado: (2018)

Development of Prostate Cancer Organoid Culture Models in Basic Medicine and Translational Research
por: Elbadawy, Mohamed, et al.
Publicado: (2020)

Novel Functions of Death-Associated Protein Kinases through Mitogen-Activated Protein Kinase-Related Signals
por: Elbadawy, Mohamed, et al.
Publicado: (2018)

Correction: Elbadawy, M., et al. Novel Functions of Death-Associated Protein Kinases through Mitogen-Activated Protein Kinase-Related Signals. Int. J. Mol. Sci. 2018, 19, 3031
por: Elbadawy, Mohamed, et al.
Publicado: (2020)

Anti-cancer activity of Chaga mushroom (Inonotus obliquus) against dog bladder cancer organoids
por: Abugomaa, Amira, et al.
Publicado: (2023)

Hedgehog Signals Mediate Anti-Cancer Drug Resistance in Three-Dimensional Primary Colorectal Cancer Organoid Culture
por: Usui, Tatsuya, et al.
Publicado: (2018)

Evaluation of the efficacy of mitochondrial fission inhibitor (Mdivi-1) using non-alcoholic steatohepatitis (NASH) liver organoids
por: Elbadawy, Mohamed, et al.
Publicado: (2023)

Efficacy of Juzen-taiho-to against vincristine-induced toxicity in dogs
por: SHINOHARA, Yuta, et al.
Publicado: (2019)

Evaluation of the Safety and Feasibility of Apheresis in Dogs: For Application in Metastatic Cancer Research
por: Yamamoto, Haru, et al.
Publicado: (2021)

Biliary excretion and pharmacokinetics of several fluoroquinolones after intravenous injection in rabbits
por: SHIMADA, Sumire, et al.
Publicado: (2023)

Establishment of 2.5D organoid culture model using 3D bladder cancer organoid culture
por: Abugomaa, Amira, et al.
Publicado: (2020)

Effects of several organophosphates on hepatic cytochrome P450 activities in rats
por: ABDOU, Rania H., et al.
Publicado: (2020)

Effect of the liquid form of traditional Chinese medicine, Hozen-S, on gastric motility in dogs
por: SHINOHARA, Yuta, et al.
Publicado: (2022)

Establishment of a novel experimental model for muscle‐invasive bladder cancer using a dog bladder cancer organoid culture
por: Elbadawy, Mohamed, et al.
Publicado: (2019)

Establishment of Intestinal Organoid from Rousettus leschenaultii and the Susceptibility to Bat-Associated Viruses, SARS-CoV-2 and Pteropine Orthoreovirus
por: Elbadawy, Mohamed, et al.
Publicado: (2021)

Therapeutic strategies against cancer stem cells in human colorectal cancer
por: Szaryńska, Magdalena, et al.
Publicado: (2017)

MYC and integrins interplay in colorectal cancer
por: Boudjadi, Salah, et al.
Publicado: (2016)

Oral pharmacokinetics of sulfadiazine and sulfamonomethoxine in female Holstein milking cows
por: TAJIMA, Tsuyoshi, et al.
Publicado: (2023)

Establishment of a dog primary prostate cancer organoid using the urine cancer stem cells
por: Usui, Tatsuya, et al.
Publicado: (2017)

Immunohistochemistry for Myc Predicts Survival in Colorectal Cancer
por: Toon, Christopher W., et al.
Publicado: (2014)

Emerging Therapeutic Agents for Colorectal Cancer
por: Nalli, Marianna, et al.
Publicado: (2021)

Therapeutic aspects of c-MYC signaling in inflammatory and cancerous colonic diseases
por: Sipos, Ferenc, et al.
Publicado: (2016)

Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc
por: Madden, Sarah K., et al.
Publicado: (2021)

The spliceosome is a therapeutic vulnerability in MYC-driven cancer
por: Hsu, Tiffany Y-T., et al.
Publicado: (2015)

Therapeutic Approaches Targeting MYC-Driven Prostate Cancer
por: Rebello, Richard J., et al.
Publicado: (2017)

Mission Possible: Advances in MYC Therapeutic Targeting in Cancer
por: Allen-Petersen, Brittany L., et al.
Publicado: (2019)

Spotlight on New Therapeutic Opportunities for MYC-Driven Cancers
por: D’Avola, Annalisa, et al.
Publicado: (2023)

c-MYC Protein Stability Is Sustained by MAPKs in Colorectal Cancer
por: Lepore Signorile, Martina, et al.
Publicado: (2022)

MYC dysfunction modulates stemness and tumorigenesis in breast cancer
por: Liu, Yiqiu, et al.
Publicado: (2021)

The MYC 3′ Wnt-Responsive Element Drives Oncogenic MYC Expression in Human Colorectal Cancer Cells
por: Rennoll, Sherri A., et al.
Publicado: (2016)

Antidepressants synergize with chemotherapy against cancer stem cells
por: Melino, Gerry
Publicado: (2015)

Therapeutic strategies targeting cancer stem cells
por: Yoshida, Go J., et al.
Publicado: (2015)

Oral absorption profiles of sulfonamides in Shiba goats: a comparison among sulfadimidine, sulfadiazine and sulfanilamide
por: ELBADAWY, Mohamed, et al.
Publicado: (2016)

Study on the Therapeutic Benefit on Lactoferrin in Patients with Colorectal Cancer Receiving Chemotherapy
por: Moastafa, Tarek M., et al.
Publicado: (2014)

Therapeutic Characteristics, Chemotherapy-Related Toxicities and Survivorship in Colorectal Cancer Patients
por: Aoullay, Zineb, et al.
Publicado: (2020)

SPDR-2 DEVELOPMENT OF A NOVEL THERAPEUTIC STRATEGY AGAINST MEDULLOBLASTOMA TARGETING MYC
por: Ito, Hiroshi, et al.
Publicado: (2022)

E3 ubiquitin ligase MAGI3 degrades c-Myc and acts as a predictor for chemotherapy response in colorectal cancer
por: Wang, Haibo, et al.
Publicado: (2022)

Dual Inhibition of Myc Transcription and PI3K Activity Effectively Targets Colorectal Cancer Stem Cells
por: Gaggianesi, Miriam, et al.
Publicado: (2022)

Patterns of methylation of the c-myc gene in human colorectal cancer progression.
por: Sharrard, R. M., et al.
Publicado: (1992)

Cannot write session to /tmp/vufind_sessions/sess_t2q8p57liifhp5tueckh6graar